-
-
-
-
-
-
-
INmune Bio, Inc. to Announce Interim Data from Phase Ib Clinical Study of XPro1595 in Patients with Alzheimer’s Disease Prior to Start of AAIC 2020
-
-
-
-
924,288 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All